JC virus, JCV, is a human neurotropic polyomavirus whose replication in glial cells causes the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML). In addition, JCV possesses oncogenic activity and expression of its transforming protein, large T-antigen (T-Ag), in several experimental animals induces tumors of neural origin. Further, the presence of JCV DNA and T-Ag have been repeatedly observed in several human malignant tissues including primitive neuroectodermal tumors and glioblastomas. Earlier studies have demonstrated that Bag3, a member of the Bcl-2-associated athanogene (Bag) family of proteins, which is implicated in autophagy and apoptosis, is downregulated upon JCV infection of glial cells and that JCV T-Ag is responsible for suppressing the activity of the BAG3 promoter. Here, we investigated the possible impact of Bag3 on T-Ag expression in JCV-infected human primary glial cells as well as in cells derived from T-Ag-induced medulloblastoma in transgenic animals. Results from these studies revealed that overexpression of Bag3 drastically decreases the level of T-Ag expression by inducing the autophagic degradation of the viral protein. Interestingly, this event leads to the inhibition of JCV infection of glial cells, suggesting that the reduced levels of T-antigen seen upon the overexpression of Bag3 has a biological impact on the viral lytic cycle. Results from protein-protein interaction studies showed that T-Ag and Bag3 physically interact with each other through the zinc-finger of T-Ag and the proline rich domains of Bag3, and this interaction is important for the autophagic degradation of T-Ag. Our observations open a new avenue of research for better understanding of virus-host interaction by investigating the interplay between T-Ag and Bag3, and their impact on the development of JCV-associated diseases.
References
[1]
Weber T (2008) Progressive Multifocal Leukoencephalopathy. Neurol. Clin. 26: 833–854.
[2]
Moens U, Johannessen M (2008) Human polyomaviruses and cancer: expanding repertoire. J Dtsch Dermatol Ges. 6: 704–708.
[3]
Safak M, Major E, Khalili K (2005) Human polyomavirus, JC virus, and progressive multifocal encephalopathy. In:. Gendelman HE, Everall IP, Lipton SA, Swindells S, editors. The Neurology of AIDS. New York: Oxford University Press. 461–474.
[4]
Berger JR, Concha M (1995) Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare, J. Neurovirology. 1: 5–18.
[5]
Miller JR, Barrett RE, Britton CB, Tapper ML, Bahr GS, et al. (1982) Progressive multifocal leukoencephalopathy in a male homosexual with T-cell immune deficiency. N Engl J Med. 307: 1436–1438.
[6]
Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, et al. (2005) Natalizumab induction and maintenance therapy for Crohn’s disease. N Engl J Med 353: 1912–1925.
[7]
Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 353: 375–81.
[8]
Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353: 369–374.
[9]
Carson KR, Focosi D, Major EO, Petrini M, Richey EA, et al. (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol. 10: 816–824.
[10]
White MK, Khalili K (2005) Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer 41: 2537–2548.
[11]
White MK, Khalili K (2006) Interaction of retinoblastoma protein family members with large T-antigen of primate polyomaviruses. Oncogene 25: 5286–5293.
[12]
Kelley WL, Georgopoulos C (1997) The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc Natl Acad Sci U S A 94: 3679–3684.
[13]
Khalili K, Sariyer IK, Safak M (2008) Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol 215: 309–319.
[14]
Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, et al. (2007) Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 39: 1337–1342.
[15]
Basile A, Darbinian N, Kaminski R, White MK, Gentilella A, et al. (1999) Evidence for modulation of BAG3 by polyomavirus JC early protein. J Gen Virol. 90: 1629–1640.
[16]
Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S, et al. (1999) Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death. Oncogene 18: 6183–6190.
[17]
Takayama S, Xie Z, Reed JC (1999) An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 274: 781–786.
[18]
Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, et al. (2008) BAG3 gene expression is regulated by heat shock factor 1. J Cell Physiol 215: 575–577.
[19]
Rosati A, Khalili K, Deshmane SL, Radhakrishnan S Pascale M, et al. (2009) BAG3 protein regulates caspase-3 activation in HIV-1-infected human primary microglial cells. J Cell Physiol 218: 264–267.
[20]
Bonelli P, Petrella A, Rosati A, Roman MF, Lerose R, et al. (2004) BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 18: 358–360.
[21]
Festa M, Del Valle L, Khalili K, Franco R, Scognamiglio G, et al. (2011) BAG3 protein is overexpressed in human glioblastoma and is a potential target for therapy. Am J Pathol. 178: 2504–2512.
[22]
Krynska B, Del Valle L, Gordon J, Otte J, Croul S, et al. (2000) Identification of a novel p53 mutation in JCV-induced mouse medulloblastoma. Virology 274: 65–74.
[23]
Carra S, Seguin SJ, Landry J (2008a) HspB8 and Bag3: a new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy. 4: 237–239.
[24]
Carra S, Seguin SJ, Lambert H, Landry J (2008b) HspB8 chaperone activity toward poly (Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J Biol Chem 283: 1437–1444.
[25]
Carra S, Brunsting JF, Lambert H, Landry J, Kampinga HH (2009) HspB8 participates in protein quality control by a non-chaperone-like mechanism that requires eIF2{alpha} phosphorylation. J Biol Chem. 284: 5523–5532.
[26]
Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC (2011) BAG3: a multifaceted protein that regulates major cell pathways. Cell Death 2: e141.
[27]
Gentilella A, Khalili K (2011) BAG3 Expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner. J Biol Chem 286: 9205–9215.
[28]
Beere HM (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115: 2633–2639.
[29]
Behl C (2011) BAG3 and friends: co-chaperones in selective autophagy during aging and disease.Autophagy. 7: 795–798.
[30]
Sawai ET, Butel JS (1989) Association of a cellular heat shock protein with simian virus 40 large T antigen in transformed cells. J Virol 63: 3961–3973.
[31]
Doong H, Price J, Kim YS, Gasbarre C, Probst J, et al. (2000) CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene. 19: 4385–4395.
[32]
Sariyer IK, Khalili K (2011) Regulation of human neurotropic polyomavirus, JCV, by alternative splicing factor, SF2/ASF, in glial cells. PLoS One 6: e14630.
[33]
Gentilella A, Passiatore G, Deshmane S, Turco MC, Khalili K (2008) Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene 27: 5011–5018.
[34]
Arndt V, Dick N, Tawo R, Dreiseidler M, Wenzel D, et al. (2010) Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr. Biol. 20: 143–148.
[35]
Safak M, Gallia GL, Ansari SA, Khalili K (1999) Physical and functional interaction between the Y-box binding protein YB-1 and human polyomavirus JC virus large T antigen. J Virol 73: 10146–10157.
[36]
Chang CF, Gallia GL, Muralidharan V, Chen NN, Zoltick P, et al. (1996) Evidence that replication of human neurotropic JC virus DNA in glial cells is regulated by the sequence-specific single-stranded DNA-binding protein Pur alpha. J Virol 70: 4150–4156.
[37]
Akan I, Sariyer IK, Biffi R, Palermo V, Woolridge S, et al. (2006) Human polyomavirus JCV late leader peptide region contains important regulatory elements. Virology 349: 66–78.
